Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae

References

• Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis 2014; 59 Suppl 3:S97-100; PMID:25261548; https://doi.org/10.1093/cid/ciu542
   PubMed Web of Science ®Google Scholar
• Camins BC, King MD, Wells JB, Googe HL, Patel M, Kourbatova EV, Blumberg HM. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol 2009; 30:931-8; PMID:19712032; https://doi.org/10.1086/605924
   PubMed Web of Science ®Google Scholar
• Report to the President on Combating Antibiotic Resistance. Executive Office of the President: President's Council of Advisors on Science and Technology, 2014
   Google Scholar
• Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, et al. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016; 62:e51-77; PMID:27080992; https://doi.org/10.1093/cid/ciw118
   PubMed Web of Science ®Google Scholar
• Nowak MA, Nelson RE, Breidenbach JL, Thompson PA, Carson PJ. Clinical and economic outcomes of a prospective antimicrobial stewardship program. Am J Health Syst Pharm 2012; 69:1500-8; PMID:22899745; https://doi.org/10.2146/ajhp110603
   PubMed Web of Science ®Google Scholar
• Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, Brolund A, Giske CG. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009; 53:3365-70; PMID:19506063; https://doi.org/10.1128/AAC.00126-09
   PubMed Web of Science ®Google Scholar
• Kitchel B, Sundin DR, Patel JB. Regional dissemination of KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2009; 53:4511-3; PMID:19687250; https://doi.org/10.1128/AAC.00784-09
   PubMed Web of Science ®Google Scholar
• Wendt C, Schütt S, Dalpke AH, Konrad M, Mieth M, Trierweiler-Hauke B, Weigand MA, Zimmermann S, Biehler K, Jonas D. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010; 29:563-70; PMID:20213255; https://doi.org/10.1007/s10096-010-0896-0
   PubMed Web of Science ®Google Scholar
• Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 2011; 66:307-12; PMID:21131324; https://doi.org/10.1093/jac/dkq431
   PubMed Web of Science ®Google Scholar
• Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, Quinn JP, Colombian Nosocomial Resistance Study Group. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 2006; 50:2880-2; PMID:16870793; https://doi.org/10.1128/AAC.00186-06
   PubMed Web of Science ®Google Scholar
• Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, Prekates A, Themeli-Digalaki K, Tsakris A. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 2011; 17:1798-803; PMID:21595793; https://doi.org/10.1111/j.1469-0691.2011.03514.x
   PubMed Web of Science ®Google Scholar
• Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011; 53:60-7; PMID:21653305; https://doi.org/10.1093/cid/cir202
   PubMed Web of Science ®Google Scholar
• Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009; 30:1180-5; PMID:19860564; https://doi.org/10.1086/648451
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52:1028-33; PMID:18086836; https://doi.org/10.1128/AAC.01020-07
   PubMed Web of Science ®Google Scholar
• Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29:1099-106; PMID:18973455; https://doi.org/10.1086/592412
   PubMed Web of Science ®Google Scholar
• Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS, Eisenstein BI, Gerding D, Lynfield R, Reller LB, Rex J, et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 2011; 52 Suppl 5:S397-428; PMID:21474585
   PubMed Web of Science ®Google Scholar
• Spellberg B, Bartlett JG, Gilbert DN. The future of antibiotics and resistance. N Engl J Med 2013; 368:299-302; PMID:23343059; https://doi.org/10.1056/NEJMp1215093
   PubMed Web of Science ®Google Scholar
• Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother 2007; 60:1124-30; PMID:17884829; https://doi.org/10.1093/jac/dkm356
   PubMed Web of Science ®Google Scholar
• Kritsotakis EI, Tsioutis C, Roumbelaki M, Christidou A, Gikas A. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{β}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother 2011; 66:1383-91; PMID:21454344; https://doi.org/10.1093/jac/dkr116
   PubMed Web of Science ®Google Scholar
• Caballero S, Carter R, Ke X, Sušac B, Leiner IM, Kim GJ, et al. Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae. PLoS Pathog 2015; 11:e1005132; PMID:26334306; https://doi.org/10.1371/journal.ppat.1005132
   PubMed Web of Science ®Google Scholar
• Patel N, Harrington S, Dihmess A, Woo B, Masoud R, Martis P, Fiorenza M, Graffunder E, Evans A, McNutt LA, et al. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. J Antimicrob Chemother 2011; 66:1600-8; PMID:21508008; https://doi.org/10.1093/jac/dkr156
   PubMed Web of Science ®Google Scholar
• Lai CC, Shi ZY, Chen YH, Wang FD. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison. J Microbiol Immunol Infect 2016; 49:74-82; PMID:26586483; https://doi.org/10.1016/j.jmii.2015.05.011
   PubMedGoogle Scholar
• Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 2011; 66:1223-30; PMID:21460369; https://doi.org/10.1093/jac/dkr137
   PubMed Web of Science ®Google Scholar
• Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G, Landman D, Bratu S, Augenbraun M, Quale J. Success of an Infection Control Program to Reduce the Spread of Carbapenem Resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009; 30:447-52; PMID:19301985; https://doi.org/10.1086/596734
   PubMed Web of Science ®Google Scholar
• Munoz-Price LS, Hayden MK, Lolans K, Won S, Calvert K, Lin M, Stemer A, Weinstein R. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010; 31:341-7; PMID:20175685; https://doi.org/10.1086/651097
   PubMed Web of Science ®Google Scholar
• Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal I, Shachar D, Zlotkin A, Smollan G, Rahav G. Potential role of active surveillance in the control of a hospital wide outbreak of carbapenem resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010; 31:620-6; PMID:20370465; https://doi.org/10.1086/652528
   PubMed Web of Science ®Google Scholar
• Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136:834-44; PMID:12044132; https://doi.org/10.7326/0003-4819-136-11-200206040-00013
   PubMed Web of Science ®Google Scholar
• Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med 2015; 175:626-33; PMID:25705994; https://doi.org/10.1001/jamainternmed.2014.8273
   PubMed Web of Science ®Google Scholar
• Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis 2011; 53 Suppl 1:S23-8; quiz S9-30; https://doi.org/10.1093/cid/cir365
   PubMed Web of Science ®Google Scholar
• Pakyz AL, Oinonen M, Polk RE. Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009; 53:1983-6; PMID:19273670; https://doi.org/10.1128/AAC.01535-08
   PubMed Web of Science ®Google Scholar
• Spellberg B, Srinivasan A, Chambers HF. New societal approaches to empowering antibiotic stewardship. JAMA 2016; 315:1229-30; PMID:26914942; https://doi.org/10.1001/jama.2016.1346
   PubMed Web of Science ®Google Scholar
• Wenzler E, Wong JR, Goff DA, Jankowski CA, Bauer KA. Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials. Antibiotics (Basel) 2016; 5(1):6; PMID:27025521
   PubMed Web of Science ®Google Scholar
• Bauer KA, Perez KK, Forrest GN, Goff DA. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis 2014; 59 Suppl 3:S134-45; PMID:25261540; https://doi.org/10.1093/cid/ciu547
   PubMed Web of Science ®Google Scholar
• Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Bartzavali C, Anastassiou ED, et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 2012; 67:2976-81; PMID:22927316; https://doi.org/10.1093/jac/dks316
   PubMed Web of Science ®Google Scholar
• Perez F, Endimiani A, Ray AJ, Decker BK, Wallace CJ, Hujer KM, Ecker DJ, Adams MD, Toltzis P, Dul MJ, et al. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J Antimicrob Chemother 2010; 65:1807-18; PMID:20513702; https://doi.org/10.1093/jac/dkq191
   PubMed Web of Science ®Google Scholar
• Chopra T. Effective Antibiotic Stewardship Programs at Long-Term Care Facilities: A Silver Lining in the Post-Antibiotic Era. In: Rivard CM, ed. Annals of Long Term Care: HMP Communications, 2015
   Google Scholar
• Marquez P, Terashita D, Dassey D, Mascola L. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol 2013; 34:144-50; PMID:23295560; https://doi.org/10.1086/669087
   PubMed Web of Science ®Google Scholar
• Perez F, Van Duin D. Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients. Cleve Clin J Med 2013; 80:225-33; PMID:23547093; https://doi.org/10.3949/ccjm.80a.12182
   PubMed Web of Science ®Google Scholar
• Stach LM, Hedican EB, Herigon JC, Jackson MA, Newland JG. Clinicians' attitudes towards an antimicrobial stewardship program at a children's hospital. J Ped Infect Dis 2012; 1:190-7; https://doi.org/10.1093/jpids/pis045
   Google Scholar